UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000014299
Receipt No. R000016650
Scientific Title Phase II study of erlotinib monotherapy for patients with advanced stage of non-small cell lung cancer, undetectable epidermal growth factor receptor (EGFR) mutations by PNA LNA PCR clamp method, but positive immuno-staining with anti-EGFR mutation-specific antibodies.
Date of disclosure of the study information 2014/07/01
Last modified on 2016/08/05 13:23:11

No. Disposal Last modified on Item of update
1 Insert 2014/06/18 12:23:01
2 Update 2014/06/18 16:41:40 Recruitment status
3 Update 2014/12/19 09:40:11 Key exclusion criteria
4 Update 2016/08/05 13:23:11 Recruitment status


Contact us.